E90 Group Company Limited – Trademark Portfolio
Entity Type: 99
E90 Group Company Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MAIJEB and SIAMWAN. The owner is based in Phuket, Phuket.
Box No. 2 T. Kathu
Phuket, Phuket 83120 , TH
Showing of trademarks Trademarks
Trademark Classifications
E90 Group Company Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does E90 Group Company Limited have?
E90 Group Company Limited has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does E90 Group Company Limited file in?
E90 Group Company Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are E90 Group Company Limited's most well-known trademarks?
E90 Group Company Limited's registered trademark portfolio includes well-known marks such as MAIJEB and SIAMWAN. These are among 3 currently registered trademarks in the portfolio.
What is E90 Group Company Limited's trademark registration success rate?
E90 Group Company Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.